B02AA02 - Tranexamic Acid |
Not porphyrinogenic |
NP |
Rationale
Aminoacid. No CYP-interactions.
Chemical description
Amino acid plasmin inhibitor administered as tablets or infusion in situations with fibrinolysis or risk for fibrinolytic bleeding. Metabolized by acetylation and deamination
IPNet drug reports
Uneventful use reported in 4 patients with acute porphyria.
Similar drugs
© NAPOS 2024